treprostinil 0.016 MG

RxNorm concept 2602749, clinical drug component (scdc).

RxCUI: 2602749
Term type: Clinical drug component (SCDC)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2602749 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

treprostinil 343048

Related concepts

treprostinil 0.016 MG Inhalation Powder (SCD, constitutes)
treprostinil 0.016 MG Inhalation Powder [Tyvaso] (SBD, constitutes)
treprostinil (IN, has ingredient)
treprostinil 0.016 MG [Tyvaso] (SBDC, has tradename)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 2602749 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2602749 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2602749. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.